Existing reports have shown that oral squamous cell carcinoma, breast cancer, and colorectal cancer patients with a lower expression of CSNK1E exhibited a considerably longer overall survival rate than patients with higher expression of CSNK1E [26,27,28]. Here, CSNK1E is linked to oral cavity squamous cell carcinoma.